RTALB PEER ANALYSIS

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. — metric-by-metric comparison with peers and the industry median

RTALBRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

🇹🇷 Turkey · IS · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

RTALBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	RTALB	OTLK	PDSB	ATNM	SGMO	PMVP	Ind. Median
P/E	4.89	—	—	—	—	—	17.91
P/B	0.61	-1.27	12.16	13.30	-1.52●	0.74	3.51
EV/EBITDA	74.61	—	—	—	—	—	14.82
P/S	6.67	110.89	—	340.49	0.83●	—	10.89

Financial Health
Metric	RTALB	OTLK	PDSB	ATNM	SGMO	PMVP	Ind. Median
Current Ratio	1.21	0.54	2.26	5.89	0.70	11.14●	5.90
Debt/Equity	1.2%	-93.8%	407.5%	65.9%	-102.0%●	0.3%	10.9%
NetDebt/EBITDA	0.90	-0.31●	0.21	1.79	0.07	1.19	1.15

Profitability
Metric	RTALB	OTLK	PDSB	ATNM	SGMO	PMVP	Ind. Median
Net Margin	136.3%●	-18,297.5%	—	-26,078.9%	-356.9%	—	-125.7%
ROE	15.1%●	—	-254.1%	-167.7%	—	-63.2%	-47.5%
ROA	13.1%●	-297.6%	-93.1%	-41.1%	-168.8%	-58.6%	-35.8%
EBITDA Margin	9.0%●	-18,634.1%	—	-25,150.0%	-339.9%	—	-105.8%

Growth + Dividend
Metric	RTALB	OTLK	PDSB	ATNM	SGMO	PMVP	Ind. Median
Rev. Growth	24.0%●	-2.1%	-100.0%	-88.9%	-45.8%	—	5.1%
NI Growth	134.0%	—	—	—	—	—	12.1%
Div. Yield	0.0%	—	—	—	—	—	0.2%
Payout	0.0%	—	—	—	—	—	0.0%

Valuation
Metric	RTALB	ANGEN	TRILC	LKMNH	MEDTR	SEYKM	Ind. Median
P/E	4.89●	—	—	22.46	596.83	264.22	17.91
P/B	0.61	1.32	0.61●	1.16	1.08	1.64	3.51
EV/EBITDA	74.61	34.77	3.51●	4.65	10.93	416.64	14.82
P/S	6.67	2.95	0.23●	0.71	1.18	3.50	10.89

Financial Health
Metric	RTALB	ANGEN	TRILC	LKMNH	MEDTR	SEYKM	Ind. Median
Current Ratio	1.21	2.31	0.99	0.83	3.58	6.82●	5.90
Debt/Equity	1.2%	28.1%	207.6%	99.0%	1.0%	0.0%●	10.9%
NetDebt/EBITDA	0.90	4.71	2.71	1.96	-1.64	-168.37●	1.15

Profitability
Metric	RTALB	ANGEN	TRILC	LKMNH	MEDTR	SEYKM	Ind. Median
Net Margin	136.3%●	-45.0%	-2.2%	3.2%	0.2%	1.3%	-125.7%
ROE	15.1%●	-21.0%	-6.0%	5.6%	0.2%	0.7%	-47.5%
ROA	13.1%●	-15.7%	-1.8%	2.7%	0.2%	0.6%	-35.8%
EBITDA Margin	9.0%	9.8%	28.5%●	26.4%	9.4%	0.6%	-105.8%

Growth + Dividend
Metric	RTALB	ANGEN	TRILC	LKMNH	MEDTR	SEYKM	Ind. Median
Rev. Growth	24.0%	11.7%	32.0%●	19.8%	6.5%	-24.8%	5.1%
NI Growth	134.0%●	—	—	-44.2%	-62.9%	—	12.1%
Div. Yield	0.0%	0.0%	0.0%	3.6%●	1.1%	0.0%	0.2%
Payout	0.0%	0.0%	0.0%	81.3%	656.3%	0.0%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on RTALB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.